
Am J Psychiatry 159:768-774, May 2002
© 2002 American Psychiatric Association
PET Study of [18F]6-Fluoro-L-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium
Lakshmi N. Yatham, M.B.B.S.,
Peter F. Liddle, Ph.D., M.B.B.S.,
I-Shin Shiah, M.D.,
Raymond W. Lam, M.D.,
Elton Ngan, M.D.,
Gayle Scarrow, B.A.,
Miguel Imperial, B.A.,
Jon Stoessl, M.D.,
Vesna Sossi, Ph.D., and
Thomas J. Ruth, Ph.D.
OBJECTIVE: Although dopaminergic hyperactivity has been implicated in mania, the precise location in the brain of the abnormality is unclear. This study assessed presynaptic dopamine function in neuroleptic- and mood-stabilizer-naive nonpsychotic first-episode manic patients before and after treatment with divalproex sodium by measuring [18F]6-fluoro-L-dopa ([18F]DOPA) uptake in the striatum with positron emission tomography (PET). METHOD: Thirteen patients with DSM-IV bipolar I disorder, manic episode, and 13 healthy comparison subjects underwent [18F]DOPA PET scans. Ten of the 13 patients had repeat PET scans 26 weeks after beginning treatment with divalproex sodium monotherapy. [18F]DOPA uptake rate constants (Ki values) in the striatum were calculated by using graphical analysis with activity from the occipital cortex as the input function. RESULTS: No significant differences in [18F]DOPA uptake rate constants in the striatum were found between the manic patients and the comparison subjects. After treatment with divalproex sodium, [18F]DOPA rate constants were significantly reduced in the patients and were lower in the patients than in the comparison subjects. CONCLUSIONS: Although presynaptic dopamine function as reflected by [18F]DOPA uptake is not altered in mania, presynaptic dopamine function in manic patients was lower after treatment with divalproex sodium.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Kumakura and P. Cumming
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Neuroscientist,
December 1, 2009;
15(6):
635 - 650.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. D. Howes and S. Kapur
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Schizophr Bull,
May 1, 2009;
35(3):
549 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Reeves, R. Brown, R. Howard, and P. Grasby
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Neurology,
February 10, 2009;
72(6):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. D. Howes, A. J. Montgomery, M.-C. Asselin, R. M. Murray, I. Valli, P. Tabraham, E. Bramon-Bosch, L. Valmaggia, L. Johns, M. Broome, et al.
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Arch Gen Psychiatry,
January 1, 2009;
66(1):
13 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. D. HOWES, A. J. MONTGOMERY, M. ASSELIN, R. M. MURRAY, P. M. GRASBY, and P. K. McGUIRE
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
The British Journal of Psychiatry,
December 1, 2007;
191(51):
s13 - s18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mazza, M. Di Nicola, G. D. Marca, L. Janiri, P. Bria, and S. Mazza
Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions
Neuroscientist,
August 1, 2007;
13(4):
392 - 404.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Lohr and M. P. Caligiuri
Abnormalities in Motor Physiology in Bipolar Disorder
J Neuropsychiatry Clin Neurosci,
August 1, 2006;
18(3):
342 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hwang, I. K. Lyoo, S. R. Dager, S. D. Friedman, J. S. Oh, J. Y. Lee, S. J. Kim, D. L. Dunner, and P. F. Renshaw
Basal Ganglia Shape Alterations in Bipolar Disorder
Am J Psychiatry,
February 1, 2006;
163(2):
276 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Biraben, F. Semah, M. -J. Ribeiro, G. Douaud, P. Remy, and A. Depaulis
PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy
Neurology,
July 13, 2004;
63(1):
73 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Yatham, P. F. Liddle, R. W. Lam, I-S. Shiah, C. Lane, A. J. Stoessl, V. Sossi, and T. J. Ruth
PET Study of the Effects of Valproate on Dopamine D2 Receptors in Neuroleptic- and Mood-Stabilizer-Naive Patients With Nonpsychotic Mania
Am J Psychiatry,
October 1, 2002;
159(10):
1718 - 1723.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|